View in EDS PDF Full Text

HLA class I-restricted MYD88 L265P-derived peptides as specific targets for lymphoma immunotherapy.

Saved in:
Bibliographic Details
Title: HLA class I-restricted MYD88 L265P-derived peptides as specific targets for lymphoma immunotherapy.
Authors: Nelde, Annika1, Walz, Juliane Sarah2, Kowalewski, Daniel Johannes1, Schuster, Heiko1, Wolz, Olaf-Oliver1, Peper, Janet Kerstin1, Cardona Gloria, Yamel1, Langerak, Anton W.3, Muggen, Alice F.3, Claus, Rainer4, Bonzheim, Irina5, Fend, Falko5, Salih, Helmut Rainer2,6, Kanz, Lothar2, Rammensee, Hans-Georg1,7, Stevanović, Stefan1,7, Weber, Alexander N. R.1
Source: OncoImmunology. 2017, Vol. 6 Issue 3, pN.PAG-N.PAG. 1p.
Database: Academic Search Ultimate
Description
ISSN:21624011
DOI:10.1080/2162402X.2016.1219825